Stockscreener 앱 받기
55.00
1.72%
-0.96
Crispr Therapeutics Ag 주식(CRSP)의 최신 뉴스
Blair William & Co. IL Has $2.32 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Cetera Investment Advisers Has $1.97 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Barclays Issues Positive Forecast for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Westwood Holdings Group Inc. - MarketBeat
CRISPR Therapeutics AG Insider Buying: Douglas Treco Acquires 20,000 Shares - AInvest
CRISPR Therapeutics (NASDAQ:CRSP) Given "Buy" Rating at Chardan Capital - MarketBeat
Crispr Therapeutics Faces Stock Dip Amid Promising Developments - TipRanks
Crispr Therapeutics AG (CRSP) Gets a Buy from Truist Financial - The Globe and Mail
Royal Bank Of Canada Increases CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $42.00 - MarketBeat
Director Makes Bold Move with Major Stock Purchase in Crispr Therapeutics AG! - TipRanks
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock - MSN
Equities Analysts Issue Forecasts for CRSP FY2025 Earnings - MarketBeat
Crispr Therapeutics price target raised to $12 from $10 at Barclays - TipRanks
CRISPR Therapeutics (NASDAQ:CRSP) Posts Quarterly Earnings Results - MarketBeat
CRSP Stock Analysis: What’s Going on with Crispr Therapeutics AG? - Markets.com
Brookline Capital Management Estimates CRSP Q3 Earnings - MarketBeat
Leerink Partnrs Has Pessimistic View of CRSP Q3 Earnings - MarketBeat
Crispr Therapeutics AG: Strong Sales Growth and Global Expansion Justify Buy Rating - TipRanks
Research Analysts Set Expectations for CRSP FY2027 Earnings - MarketBeat
HC Wainwright Issues Positive Forecast for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price - MarketBeat
CRISPR Therapeutics stock price target raised to $80 by H.C. Wainwright - Investing.com Nigeria
Banque Cantonale Vaudoise Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Privium Fund Management B.V. Acquires 25,100 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Crispr Earnings: Casgevy Launch Gains Momentum; Early-Stage Pipeline Progresses; Shares Undervalued - Morningstar
CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption - MSN
CRISPR Therapeutics Shares Drop 6.71% on Q2 Losses and $96M Charge as $250M Volume Ranks 475th - AInvest
CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap DownShould You Sell? - MarketBeat
Up 50% in 3 Months, Is This Stock Still a Buy? - The Motley Fool
Crispr Therapeutics AG: Strong Financial Foundation and Promising Pipeline Amidst Strategic Growth - TipRanks
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics Plunges 9.63% Ahead of Q2 Earnings - AInvest
Crispr Therapeutics AG: Promising Growth and Expanding Pipeline Justify Buy Rating - TipRanks
Bayforest Capital Ltd Purchases Shares of 12,424 CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates - MSN
CRISPR Therapeutics AG reports results for the quarter ended June 30Earnings Summary - TradingView
Crispr Therapeutics shares tumble after significant earnings miss By Investing.com - Investing.com Nigeria
Crispr Therapeutics shares tumble after significant earnings miss - Investing.com
Crispr Therapeutics earnings missed by $1.00, revenue fell short of estimates - Investing.com
CRISPR Therapeutics AG SEC 10-Q Report - TradingView
CRISPR Therapeutics Q2 revenue misses estimates, net loss widens - MarketScreener
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire
Published on: 2025-08-04 01:34:11 - Jammu Links News
What analysts say about CRISPR Therapeutics AG stockCapitalize on market trends with confidence - Jammu Links News
What are CRISPR Therapeutics AG company’s key revenue driversCapitalize on fast-moving stock trends - Jammu Links News
What are the latest earnings results for CRISPR Therapeutics AGMaximize gains with data-driven stock picks - Jammu Links News
What is Zacks Research's Estimate for CRSP Q2 Earnings? - MarketBeat
When is CRISPR Therapeutics AG stock expected to show significant growthFree Trading Strategy Suggestions - Jammu Links News
What drives CRISPR Therapeutics AG stock priceAchieve consistent double-digit growth - Jammu Links News
Published on: 2025-08-03 05:26:58 - Jammu Links News
CRISPR Therapeutics (CRSP) Sees 47% Price Increase Over Last Quarter - simplywall.st
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN
Cerity Partners LLC Invests $216,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 4.1%Here's What Happened - MarketBeat
0.24%
3.39%
자본화:
|
볼륨(24시간):